Your browser doesn't support javascript.
loading
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse, Acacia N; LaPorte, Kathryn M; Malek, Thomas R.
Afiliação
  • Shouse AN; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • LaPorte KM; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Malek TR; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Electronic address: tmalek@med.miami.edu.
Immunity ; 57(3): 414-428, 2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38479359
ABSTRACT
Interleukin-2 (IL-2) is a critical cytokine for T cell peripheral tolerance and immunity. Here, we review how IL-2 interaction with the high-affinity IL-2 receptor (IL-2R) supports the development and homeostasis of regulatory T cells and contributes to the differentiation of helper, cytotoxic, and memorycells. A critical element for each T cell population is the expression of CD25 (Il2rα), which heightens the receptor affinity for IL-2. Signaling through the high-affinity IL-2R also reinvigorates CD8+ exhausted T (Tex) cells in response to checkpoint blockade. We consider the molecular underpinnings reflecting how IL-2R signaling impacts these various T cell subsets and the implications for enhancing IL-2-dependent immunotherapy of autoimmunity, other inflammatory disorders, and cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article